Federated Hermes, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,110,700 shares of RARE stock, worth $90.6 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

2,110,700

Previous 2,107,025 0.17%

Holding current value

$90.6 Million

Previous $86.6 Million 35.39%

% of portfolio

0.27%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$40.21 - $59.36 $147,771 - $218,148	3,675 Added 0.17%	2,110,700 $117 Million
Q2 2024 Aug 08, 2024	BUY	$37.42 - $51.61 $6.3 Million - $8.69 Million	168,345 Added 8.68%	2,107,025 $86.6 Million
Q1 2024 May 14, 2024	SELL	$43.02 - $53.69 $21.8 Million - $27.3 Million	-507,820 Reduced 20.76%	1,938,680 $90.5 Million
Q4 2023 Jan 31, 2024	BUY	$31.73 - $49.19 $7.93 Million - $12.3 Million	250,000 Added 11.38%	2,446,500 $117 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $14.7 Million - $19.6 Million	419,900 Added 23.64%	2,196,500 $78.3 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $28 Million - $39.1 Million	-749,000 Reduced 29.66%	1,776,600 $82 Million
Q1 2023 May 08, 2023	SELL	$36.99 - $48.71 $21 Million - $27.7 Million	-568,900 Reduced 18.38%	2,525,600 $101 Million
Q4 2022 Feb 13, 2023	SELL	$33.72 - $46.33 $24.3 Million - $33.4 Million	-721,897 Reduced 18.92%	3,094,500 $143 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $771,547 - $1.28 Million	19,308 Added 0.51%	3,816,397 $158 Million
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $8.73 Million - $16.3 Million	-190,639 Reduced 4.78%	3,797,089 $227 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $53,367 - $72,415	858 Added 0.02%	3,987,728 $290 Million
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $11,941 - $14,233	-162 Reduced -0.0%	3,986,870 $335 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $10.6 Million - $13.9 Million	135,722 Added 3.52%	3,987,032 $360 Million
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $5.63 Million - $7.07 Million	-61,098 Reduced 1.56%	3,851,310 $367 Million
Q1 2021 May 13, 2021	SELL	$106.9 - $167.73 $39.4 Million - $61.7 Million	-368,120 Reduced 8.6%	3,912,408 $445 Million
Q4 2020 Feb 12, 2021	BUY	$84.4 - $177.39 $15.7 Million - $33 Million	186,213 Added 4.55%	4,280,528 $593 Million
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $1.02 Million - $1.26 Million	13,956 Added 0.34%	4,094,315 $337 Million
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $2.98 Million - $4.97 Million	63,599 Added 1.58%	4,080,359 $319 Million
Q1 2020 May 13, 2020	BUY	$33.8 - $62.9 $35.3 Million - $65.7 Million	1,044,752 Added 35.15%	4,016,760 $178 Million
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $4.25 Million - $5.39 Million	117,698 Added 4.12%	2,972,008 $127 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $45.9 Million - $68.1 Million	1,079,658 Added 60.84%	2,854,310 $122 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $1.39 Million - $1.89 Million	25,378 Added 1.45%	1,774,652 $113 Million
Q1 2019 May 10, 2019	BUY	$39.87 - $69.36 $18.8 Million - $32.7 Million	471,955 Added 36.95%	1,749,274 $121 Million
Q4 2018 Feb 13, 2019	SELL	$38.89 - $77.3 $8.05 Million - $16 Million	-206,952 Reduced 13.94%	1,277,319 $55.5 Million
Q3 2018 Nov 13, 2018	BUY	$71.81 - $90.15 $4.79 Million - $6.01 Million	66,720 Added 4.71%	1,484,271 $113 Million
Q2 2018 Aug 10, 2018	BUY	$48.54 - $85.31 $10.6 Million - $18.6 Million	218,060 Added 18.18%	1,417,551 $109 Million
Q1 2018 May 09, 2018	BUY	$44.33 - $58.52 $4.37 Million - $5.78 Million	98,691 Added 8.97%	1,199,491 $61.2 Million
Q4 2017 Feb 14, 2018	BUY	$43.54 - $57.32 $30.9 Million - $40.7 Million	709,200 Added 181.1%	1,100,800 $0
Q3 2017 Nov 13, 2017	BUY	$49.79 - $66.32 $19.5 Million - $26 Million	391,600	391,600 $20.9 Million

Others Institutions Holding RARE

# of Institutions

324

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Ultragenyx Pharmaceutical Inc. Transaction History